GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Purchase Of Investment

NextCell Pharma AB (OSTO:NXTCL) Purchase Of Investment : kr0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Purchase Of Investment?

NextCell Pharma AB's purchase of investment for the three months ended in Feb. 2024 was kr0.00 Mil. It means NextCell Pharma AB spent kr0.00 Mil on purchasing investments. NextCell Pharma AB's purchase of investment for the trailing twelve months (TTM) ended in Feb. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Nov. 2023 ), NextCell Pharma AB spent the same money on purchasing investments in Feb. 2024 (kr0.00 Mil).

NextCell Pharma AB Purchase Of Investment Historical Data

The historical data trend for NextCell Pharma AB's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Purchase Of Investment Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only -0.01 -0.08 -5.11 -1.76 -

NextCell Pharma AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NextCell Pharma AB Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NextCell Pharma AB Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Purchase Of Investment
Comparable Companies
OSTO:BIOVIC B OSTO:ALZ OSTO:ELIC XSAT:CESSA OSTO:ACE OSTO:LIPUM OSTO:SIMRIS B OSTO:ZICC NGM:GTAB B OSTO:ISOFOL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
65G:Germany
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
Website
http://www.nextcellpharma.com
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines